COMP <GO>
LQDT vs NUTX // RETURN ON INVESTED CAPITAL (ROIC)
Liquidity Services Inc. (NASDAQ) VS. Nutex Health Inc. (NASDAQ) • 15-METRIC TALLY: LQDT 2
— NUTX 10
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: NUTX
LAST: $44.62 (-1.48%) • MKT CAP: $1.42B
roic
12.90%
LAST: $200.15 (-4.74%) • MKT CAP: $1.44B
roic
85.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LQDT VS. NUTX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LQDT | NUTX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 43.80% | 50.80% | -7.00 | NUTX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 12.90% | 85.00% | -72.10 | NUTX | /roic <GO> |
| EV/EBITDA & P/E Valuation | 34.0x | 4.6x | +29.40 | NUTX | /valuation <GO> |
| Free Cash Flow Yield | 4.15% | 17.07% | -12.92 | NUTX | /fcf-yield <GO> |
| Operating Margin | 7.40% | 31.50% | -24.10 | NUTX | /operating-margins <GO> |
| Net Profit Margin | 5.90% | 8.10% | -2.20 | NUTX | /net-margins <GO> |
| Revenue Growth (YoY) | 31.20% | 82.40% | -51.20 | NUTX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 7.56 | 3.75 | +3.81 | LQDT | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 9/9 | -1.00 | NUTX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 59.3 | 53.8 | +5.50 | LQDT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 42.4x | 17.1x | +25.30 | NUTX | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.42B | $1.44B | -$19.8M | NUTX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LQDT REV | NUTX REV | LQDT GROSS % | NUTX GROSS % | LQDT FCF | NUTX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $476.7M | $875.3M | 43.8% | 50.8% | $59.0M | $245.6M |
| FY 2024 | $363.3M | $479.9M | 51.0% | 40.9% | $61.3M | $20.8M |
| FY 2023 | $314.5M | $247.6M | — | — | $47.0M | $1.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LQDT // BETA —
NUTX // BETA —